Endothelial Cells Count: The Importance of Monitoring Corneal Endothelium When Approving New Ocular Medications and Devices.

[1]  F. Mah,et al.  Effects of Netarsudil on the Corneal Endothelium: Three-Month Findings from a Phase 3 Trial. , 2020, Ophthalmology. Glaucoma.

[2]  M. Coote,et al.  24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients , 2019, Drugs.

[3]  J. Lass,et al.  Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification With or Without CyPass Micro-Stent. , 2019, American journal of ophthalmology.

[4]  K. Solomon,et al.  Safety of IBI-10090 for inflammation associated with cataract surgery: Phase 3 multicenter study. , 2018, Journal of cataract and refractive surgery.

[5]  Young H. Kwon,et al.  Glaucoma-associated corneal endothelial cell damage: A review. , 2017, Survey of ophthalmology.

[6]  M. Coote,et al.  Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial. , 2017, American journal of ophthalmology.

[7]  N. Afshari,et al.  Corneal Endothelial Cell Migration and Proliferation Enhanced by Rho Kinase (ROCK) Inhibitors in In Vitro and In Vivo Models , 2016, Investigative ophthalmology & visual science.

[8]  N. Koizumi,et al.  Rho-Associated Kinase Inhibitor Eye Drop Treatment as a Possible Medical Treatment for Fuchs Corneal Dystrophy , 2013, Cornea.

[9]  R. Beck,et al.  Endothelial morphometric measures to predict endothelial graft failure after penetrating keratoplasty. , 2013, JAMA ophthalmology.

[10]  J. McLaren,et al.  Effects of Glaucoma Medications on Corneal Endothelium, Keratocytes, and Subbasal Nerves Among Participants in the Ocular Hypertension Treatment Study , 2006, Cornea.